Trademark: MAPS 2086466
Word
MAPS
ID
2086466
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
26 March 2020
Registration Date
26 March 2020
Renewal Date
26 March 2030
Owner(s)
Service
Bennett Litigation and Commercial Law
Goods and Services:
Class 5:
Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens; none of the foregoing relating to mycobacteria or Crohn’s disease.
Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens; none of the foregoing relating to mycobacteria or Crohn’s disease.
Class 42:
Research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens; none of the foregoing relating to mycobacteria or Crohn’s disease; none of the foregoing relating to micro array patches, transdermal patches, or oral thin films.
Research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens; none of the foregoing relating to mycobacteria or Crohn’s disease; none of the foregoing relating to micro array patches, transdermal patches, or oral thin films.